Advertisement
About Definium Therapeutics
Definium Therapeutics (operating at definiumtx.com) is a clinical biopharmaceutical company engineered for developing novel product candidates to treat brain health disorders. Founded in 2019 by Jamon "JR" Rahn, Stephen Hurst, and Scott Freeman and headquartered in New York, Definium Therapeutics is forging a new era in psychiatry by harnessing the full therapeutic potential of psychedelic medicine. Under the hood, the company is applying precision to psychedelic medicine. This allows researchers and patients to explore new treatment options for brain health disorders. Backed by a $259 million equity financing in 4Q 2025.
Founded In2019
Company Size51 - 200 Employees
IndustryBiotechnology / Mental Health / Pharmaceutical
Open Positions3 Roles
Director, Late-Stage Clinical Strategy
Remote (United States)
$215,000.00 - $250,000.00
View Role
Senior Director, Commercial Finance
Remote (United States)
$220,000.00-$270,000.00
View Role
Associate Director, Development Project Management
Remote (Global)
$150,000.00-195,000.00
View Role
Benefits and perks at Definium Therapeutics
Learn about the 4 benefits and perks Definium Therapeutics offers its remote employees.
🏥
Health & Medical
Comprehensive medical, dental, and vision coverage for you and your dependents.
✈️
Paid Time Off
Generous paid time off, holidays, and sick days to help you rest and recharge.
📈
Equity & Retirement
Competitive retirement matching and equity options to build your future wealth.
🧘
Wellness Perks
Allowances for gym memberships, mental health apps, and overall wellbeing.
Salary ranges at Definium Therapeutics
Estimated compensation ranges based on 3 active job postings.
Highest Compensation
$270k/yr
Data Availability
100%
of open roles have disclosed salaries.
Salary ranges by position
Min Max
$215,000.00 - $250,000.00
$220,000.00-$270,000.00
$150,000.00-195,000.00
$0$270k+